FBLN5 and pancreatic ductal adenocarcinoma: Hypoxic induction of FBLN5 in CAFs isolated from mouse pancreatic ductal adenocarcinoma were reversed by pharmacologic inhibition of TGF-β or PI3K/AKT [45].